API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

Rucaparib: pharmacodynamics, pharmacokinetics and side effects

Rucaparib, a potent PARP inhibitor, demonstrates strong anti-cancer activity but poses potential adverse effects.

Nov 24,2023  API

Ninhydrin hydrate: history and applications

Ninhydrin hydrate's accidental discovery led to its applications in detecting primary amino groups and developing fingerprints.

Nov 24,2023  API

Toxic hygroscopic contact reaction to N-methyl-2-pyrrolidone

Exposure to organic solvents such as NMP may result in neurological toxicity, inhalation in high concentrations causing headache, giddiness, mental confusion and nausea, and ingestion abdominal pain,

Nov 23,2023  API

Is Apigenin a dietary supplement?

Yes, apigenin can be used as a dietary supplement in everyday life, in fact, it is found in fruits, vegetables, herbs and beverages that we consume on a daily basis.

Nov 23,2023  API

Tomatine: biosynthesis, metabolism and activities

Tomatine synthesis involves hydrophobic sapogenin and hydrophilic oligosaccharide chain. Mature tomatoes transform tomatine with diverse medicinal applications.

Nov 23,2023  API

Exploring the therapeutic potential of lactoferrin: tissue regeneration, administration routes, and promise in cancer treatment

Lactoferrin shows significant promise in tissue regeneration, eye disease prevention, and potential cancer treatment.

Nov 23,2023  API

Cycloastragenol: pharmacokinetics, activities and side effects

Cycloastragenol shows potential for diverse health applications but requires further study for safety.

Nov 23,2023  API

Iridium nanomaterials: synthesis and applications

Iridium nanomaterials pose synthesis challenges due to oxide formation, yet exhibit remarkable properties for catalysis and electrochemistry.

Nov 23,2023  API

Cyclopropyl Methyl Ketone: properties, applications and safety

Cyclopropyl Methyl Ketone, a colorless, fruity-odored compound, is widely used in pharmaceuticals and chemicals but requires stringent safety measures due to its toxicity and flammability.

Nov 23,2023  API

The effect of dietary Luteolin on glycolipid metabolism disorder

Luteolin, as a natural compound with a wide range of biological activities, are an ideal dietary supplement for maintaining metabolic homeostasis, especially significantly favouring carbohydrate and l

Nov 23,2023  API
Prev12345678910...Next>  Go to Page